{"url_path":"/sec/cah/8-k/2026-08-11/item-1-01","section_key":"item-1-01","section_title":"Item 1.01 Entry into a Material Definitive Agreement","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-08-11","source_url":"https://www.sec.gov/Archives/edgar/data/721371/0000721371-26-000036-index.html","accession_number":"0000721371-26-000036","cik":"0000721371","ticker":"CAH","issuer_name":"CARDINAL HEALTH INC","edgar_url":"https://www.sec.gov/Archives/edgar/data/721371/0000721371-26-000036-index.html","primary_entity_key":"0000721371","primary_entity_name":"CARDINAL HEALTH INC"},"word_count":367,"has_tables":true,"body_markdown":"Item 1.01: Entry into a Material Definitive Agreement\n\nOn August 7, 2026, Cardinal Health, Inc., (the “Company”), Wells Fargo Bank, National Association (“WF”), as Administrative Agent, Wells Fargo Securities, LLC, BofA Securities, Inc., Goldman Sachs Bank USA, JPMorgan Chase Bank, N.A., as Joint Lead Arrangers and Joint Bookrunners, and Goldman Sachs Bank USA and JPMorgan Chase Bank, N.A., Barclays Bank plc, Deutsche Bank AG New York Branch, HSBC Bank USA, National Association, PNC Bank, National Association and The Bank of Nova Scotia, as Documentation Agents entered into an unsecured Credit Agreement (the “Credit Agreement”).\n\nThe Credit Agreement, among other things, allows the Company access to $4.0 billion of revolving credit through August 7, 2031 (the “Termination Date”). The Company is permitted, subject to certain conditions specified in the Credit Agreement, to extend the Termination Date by up to two years. The revolving credit facility replaces the Company’s existing 364-day and five-year revolving credit facilities and its existing receivables sale facility program as described in Item 1.02 of this Current Report on Form 8-K.\n\nThe Credit Agreement contains customary representations and affirmative and negative covenants. The financial covenant in the Credit Agreement requires the Company to maintain, as of the last day of any fiscal quarter, a Consolidated Net Leverage Ratio, as such term is defined in the Credit Agreement and subject to certain conditions contained therein, of no greater than 4.00 to 1.00. The Credit Agreement also contains customary events of default (including non-payment of principal or interest and breaches of covenants). The Company will use this revolving credit facility for general corporate purposes.\n\nThe foregoing summary of the Credit Agreement does not purport to be complete and is qualified in its entirety by reference to the Credit Agreement, which is filed as an exhibit hereto and is incorporated herein by reference.\n\nFrom time to time, the financial institutions party to the Credit Agreement or their affiliates have performed, and may in the future perform, various commercial banking, investment banking and other financial advisory services for the Company. The Company pays these financial institutions customary fees and expenses for these services. For example, an affiliate of WF serves as a dealer under the Company’s commercial paper program."}